ABSTRACT
Radical cystectomy is currently the treatment of choice for invasive bladder cancer and recurrent refractory cases of superficial transitional cell carcinoma (1). However, the procedure influences significantly the quality of life of these patients, especially their sexual and urinary functions. Although current oncological treatments tend to balance the benefits associated with a radical surgery and bladder preservation modalities such as chemotherapy and external beam radiation, cancer control is still inadequate compared to the surgical results (2). With the above concept, partial cystectomy has been described in many centers. However, there is an increased danger of local recurrence and the development of synchronous prostate cancer (3).
